Formoterol Fumarate Solution
Product Images NDC 73043-051

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Formoterol Fumarate (NDC 73043-051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Devatis, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

20 Mcg/2 mL-30s Carton (Carton)

20 Mcg/2 mL-30s Carton (Carton)
Carton packaging label for Formoterol fumarate inhalation solution, 20 mcg/2 mL vial, by Devatis, Inc. The label shows product name, strength, dosage form as solution for respiratory inhalation, and quantity in a vial. Includes NDC 73043-051-93, usage instructions, storage directions, patient information notice, barcodes, and manufacturer details. The design layout includes color codes and cut/crease guides.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A line graph comparing mean FEV1 (in liters) over 12 hours for Formoterol Fumarate Inhalation Solution 20 mcg (N=123) versus placebo (N=114). The graph shows the FEV1 on the y-axis and time in hours on the x-axis, illustrating higher lung function values for the treated group versus placebo over the measured period.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A line graph showing mean FEV1 (in liters) over 12 hours comparing Formoterol Fumarate Inhalation Solution 20 mcg to placebo. The Formoterol group maintains higher FEV1 levels throughout the time period compared to the placebo group.*
FDA Label Image

Figure 1 (Patient 1)

Figure 1 (Patient 1)
Instructional illustration showing hands preparing a respiratory inhalation device with a solution vial. One hand holds the inhaler mouthpiece, and the other hand is placing a solution vial into the device's medication chamber, demonstrating the first step in setup or use of the inhalation solution device.*
FDA Label Image

Figure 2 (Patient 2)

Figure 2 (Patient 2)
An instructional line drawing showing a close-up of a respiratory inhalation device with a hand holding the base and another hand attaching or removing a small cap or component. This illustration is likely part of usage or assembly instructions for Formoterol fumarate inhalation solution.*
FDA Label Image

Figures 3 And 4 (Patient 3 4)

Figures 3 And 4 (Patient 3 4)
An instructional diagram showing two steps of using a respiratory inhalation device. In the first panel, a person places the inhaler mouthpiece in their mouth, preparing to inhale medication. In the second panel, the person uses a spacer or mask attached to the inhaler for inhalation.*
FDA Label Image

Strucutral Formula (Structure)

Strucutral Formula (Structure)
Chemical structure diagram showing the molecular structure of formoterol fumarate dihydrate, including its two aromatic rings and the fumarate moiety with two water molecules indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.